Cas:175204-81-6 4-chloro-1-methylpyrazole-3-carbaldehyde manufacturer & supplier

We serve Chemical Name:4-chloro-1-methylpyrazole-3-carbaldehyde CAS:175204-81-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-chloro-1-methylpyrazole-3-carbaldehyde

Chemical Name:4-chloro-1-methylpyrazole-3-carbaldehyde
CAS.NO:175204-81-6
Synonyms:MFCD00103234;4-chloro-1-methyl-1h-pyrazole-3-carboxaldehyde
Molecular Formula:C5H5ClN2O
Molecular Weight:144.55900
HS Code:2933199090

Physical and Chemical Properties:
Melting point:83-86°C
Boiling point:251.6ºC at 760 mmHg
Density:1.37g/cm3
Index of Refraction:1.584
PSA:34.89000
Exact Mass:144.00900
LogP:0.88600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00103234 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-1-methyl-1h-pyrazole-3-carboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-1-methyl-1h-pyrazole-3-carboxaldehyde Use and application,MFCD00103234 technical grade,usp/ep/jp grade.


Related News: A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 3,4,6,11-tetrahydro-5-hydroxy-2-methyl-6,11-dioxonaphthacene-carbaldehyde manufacturers Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. 1(2H)-Isoquinolinone,3,4-dihydro-6-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]-5-(pentyloxy)- suppliers The results provided a formulation amenable to two dosage strengths by applying a proportional dosing weight method.” The product is currently in late-stage development with the New Drug Application filing expected in late 2021. 5-benzoyl-1-benzyl-1H-pyrrolo[1,2-a]imidazole-7-carboxylic acid ethyl ester vendor & factory.